SecSonar.com

PetMed Express, Inc. (PETS)

PetMed Express, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

PetMed Express, Inc. (PETS) is a Medical - Pharmaceuticals company based in US with a market capitalization of $46.7M. Revenue declined 17.2% year-over-year and free cash flow was negative at -$395K. This page tracks PETS's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 287 employees · IPO Apr 26, 1999

Valuation

Valuation & price

$2.12 · as of May 25, 2026 · -46.7% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

1.61

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$3.90$2.75$1.60Jul 25Dec 25Jul 26Jul 7, 25$3.39Jul 9, 25$3.43Jul 11, 25$3.32Jul 15, 25$3.10Jul 17, 25$3.12Jul 21, 25$3.41Jul 23, 25$3.76Jul 25, 25$3.77Jul 29, 25$3.22Jul 31, 25$3.12Aug 4, 25$3.20Aug 6, 25$3.22Aug 11, 25$3.03Aug 13, 25$3.21Aug 15, 25$2.96Aug 19, 25$3.03Aug 21, 25$3.09Aug 25, 25$3.16Aug 27, 25$3.16Aug 29, 25$3.07Sep 3, 25$3.03Sep 5, 25$3.05Sep 9, 25$2.84Sep 11, 25$2.83Sep 16, 25$2.82Sep 18, 25$2.80Sep 22, 25$2.63Sep 24, 25$2.64Sep 26, 25$2.65Sep 30, 25$2.51Oct 2, 25$2.60Oct 6, 25$2.55Oct 8, 25$2.57Oct 10, 25$2.42Oct 14, 25$2.56Oct 16, 25$2.54Oct 21, 25$2.65Oct 23, 25$2.75Oct 27, 25$2.66Oct 29, 25$2.59Oct 31, 25$2.57Nov 4, 25$2.47Nov 6, 25$2.45Nov 10, 25$2.61Nov 12, 25$2.90Nov 14, 25$2.00Nov 18, 25$1.86Nov 20, 25$1.61Nov 25, 25$1.63Nov 28, 25$1.75Dec 2, 25$1.73Dec 4, 25$1.73Dec 8, 25$1.60Dec 10, 25$1.77Dec 12, 25$2.94Dec 16, 25$3.90Dec 18, 25$3.65Dec 22, 25$3.50Dec 24, 25$3.55Dec 29, 25$3.39Jan 2, 26$3.30Jan 6, 26$3.57Jan 8, 26$3.32Jan 12, 26$3.37Jan 14, 26$3.49Jan 16, 26$3.35Jan 21, 26$3.38Jan 23, 26$3.32Jan 27, 26$3.24Jan 29, 26$3.23Feb 2, 26$3.07Feb 4, 26$3.09Feb 9, 26$2.94Feb 11, 26$2.97Feb 13, 26$3.18Feb 18, 26$3.08Feb 20, 26$2.95Feb 24, 26$2.81Feb 26, 26$2.75Mar 2, 26$2.73Mar 4, 26$2.74Mar 6, 26$2.61Mar 10, 26$2.56Mar 12, 26$2.43Mar 17, 26$2.55Mar 19, 26$2.48Mar 23, 26$2.30Mar 25, 26$2.33Mar 27, 26$2.23Mar 31, 26$2.28Apr 2, 26$2.29Apr 7, 26$2.32Apr 9, 26$2.31Apr 13, 26$2.30Apr 15, 26$2.35Apr 17, 26$2.33Apr 22, 26$2.32Apr 24, 26$2.29Apr 28, 26$2.25Apr 30, 26$2.24May 4, 26$2.27May 6, 26$2.31May 8, 26$2.28May 12, 26$2.22May 14, 26$2.25May 18, 26$2.25May 20, 26$2.23May 22, 26$2.12May 28, 26$2.20Jun 1, 26$2.17Jun 3, 26$1.78Jun 5, 26$1.68Jun 9, 26$1.71Jun 11, 26$1.84Jun 15, 26$1.83Jun 17, 26$1.80Jun 22, 26$1.81Jun 24, 26$1.79Jun 26, 26$1.76Jul 2, 26$1.98
$1.6052-week range$3.98
Loading valuation history…

Fundamentals

Key fundamentals

$46.7M

Market cap

-17.2%

Revenue growth (YoY)

30.5%

Gross margin

-$395K

Free cash flow (USD)

-$53.7M

Net debt

Net cash position

1.0%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$234.7MFY 2017$249.2MFY 2018$273.8MFY 2019$283.4MFY 2020$284.1MFY 2021$303.6MFY 2022$273.4MFY 2023$256.6MFY 2024$274.1MFY 2025$227.0M
$234.7M$227M

Free cash flow by year

2016 → 2025

FY 2016$923.0KFY 2017$36.6MFY 2018$36.7MFY 2019$44.5MFY 2020$36.5MFY 2021$37.6MFY 2022$16.7MFY 2023$22.5MFY 2024$-194.0KFY 2025$-395.0K
$923K-$395K

Gross margin by year

2021 → 2025

FY 202127.8%FY 202227.6%FY 202327.7%FY 202428.4%FY 202530.5%
27.8%30.5%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

1

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: Jun 2, 2026 (EPS $-0.19)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventDirector DepartureJun 26, 2026Filing
  • Insider buyInsider Buy $44KNINA CAPITAL HOLDINGS INC. · 10% Owner · $43.7KJun 9, 2026Filing
  • 8-K eventEarnings ReleaseJun 2, 2026Filing
  • Annual report10-K FiledJun 2, 2026Filing
  • 8-K eventAnnual Meeting AnnouncementMay 21, 2026Filing

Questions

Frequently asked questions

What is PetMed Express, Inc.'s market cap?

PetMed Express, Inc. (PETS) has a market capitalization of $46.7M.

What is PETS's P/E ratio?

A meaningful P/E ratio is not available for PETS — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is PETS's price-to-book (P/B) ratio?

PETS trades at 1.61 times book value per share.

When did PetMed Express, Inc. last report earnings?

PETS last reported earnings on June 2, 2026; the next date is not yet scheduled.

Are insiders buying PETS stock?

Yes — SEC Form 4 filings show 1 open-market insider buy and 0 sells at PetMed Express, Inc. in the last 90 days.

Same arena

Related companies in Medical - Pharmaceuticals

YI

111, Inc.

$47.9M

SDEV

Stablecoin Development Corp.

$35M

NEUP

Neuphoria Therapeutics Inc.

$28.6M

KYNB

Kyntra Bio, Inc.

$28.1M

POM

POMDOCTOR Ltd

$12.7M

HKPD

Cellyan Biotechnology Co., Ltd

$5.7M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.